Hirofumi Tamai

1.1k total citations
17 papers, 310 citations indexed

About

Hirofumi Tamai is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hirofumi Tamai has authored 17 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hirofumi Tamai's work include Dialysis and Renal Disease Management (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Blood Pressure and Hypertension Studies (2 papers). Hirofumi Tamai is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Blood Pressure and Hypertension Studies (2 papers). Hirofumi Tamai collaborates with scholars based in Japan. Hirofumi Tamai's co-authors include A Fukatsu, Sadao Matsuo, Natsumi Sakamoto, Takao Hirano, T. Matsuda, Seiichi Matsuo, Yasuhiko Ito, Shoichi Maruyama, Masashi Mizuno and Yasuhíro Suzuki and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Hirofumi Tamai

17 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hirofumi Tamai Japan	10	140	75	51	51	48	17	310
Leonarda B. Sablay United States	9	128 0.9×	59 0.8×	23 0.5×	89 1.7×	70 1.5×	14	325
Pierre Ronco France	5	176 1.3×	207 2.8×	79 1.5×	52 1.0×	31 0.6×	6	495
C Nakahara Japan	12	213 1.5×	73 1.0×	24 0.5×	82 1.6×	39 0.8×	23	361
A Gupta United Kingdom	2	310 2.2×	76 1.0×	66 1.3×	54 1.1×	45 0.9×	3	434
Shigehiro Uezono Japan	11	156 1.1×	193 2.6×	54 1.1×	52 1.0×	27 0.6×	22	442
Shun Manabe Japan	11	204 1.5×	71 0.9×	23 0.5×	38 0.7×	54 1.1×	42	368
J F M Wetzels Netherlands	15	383 2.7×	121 1.6×	49 1.0×	35 0.7×	89 1.9×	29	611
Thomas Brunkhorst Germany	9	118 0.8×	193 2.6×	52 1.0×	32 0.6×	12 0.3×	12	484
Masami Fujisaki Japan	7	180 1.3×	33 0.4×	36 0.7×	30 0.6×	70 1.5×	8	291
Goran Matic Germany	8	26 0.2×	58 0.8×	33 0.6×	35 0.7×	31 0.6×	23	330

Countries citing papers authored by Hirofumi Tamai

Since Specialization

Citations

This map shows the geographic impact of Hirofumi Tamai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Tamai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Tamai more than expected).

Fields of papers citing papers by Hirofumi Tamai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Tamai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Tamai. The network helps show where Hirofumi Tamai may publish in the future.

Co-authorship network of co-authors of Hirofumi Tamai

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Tamai. A scholar is included among the top collaborators of Hirofumi Tamai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Tamai. Hirofumi Tamai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Shimizu, Ryo, et al.. (2022). IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration. CEN Case Reports. 12(3). 270–274. 2 indexed citations

Fukatsu, Atsushi, Takeshi Ito, Takuji Ishimoto, et al.. (2022). Sex differences in clinical outcomes in Japanese incident dialysis patients: a prospective observational multicenter study. Clinical and Experimental Nephrology. 26(5). 466–475. 3 indexed citations

Shimizu, Ryo, Shoichiro Tanaka, Takeshi Ito, et al.. (2022). A case of juvenile-onset fibrillary glomerulonephritis diagnosed by mass spectrometry and immunohistochemistry of DNAJB9. CEN Case Reports. 11(4). 412–416. 2 indexed citations

Yamaguchi, Makoto, Hiroshi Kinashi, Takayuki Katsuno, et al.. (2020). The effectiveness and safety of computed tomographic peritoneography and video-assisted thoracic surgery for hydrothorax in peritoneal dialysis patients: A retrospective cohort study in Japan. PLoS ONE. 15(9). e0238602–e0238602. 9 indexed citations

Hishida, Manabu, Hirofumi Tamai, Takafumi Aoki, et al.. (2016). Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy. Clinical and Experimental Nephrology. 20(5). 795–807. 26 indexed citations

Aoki, Takafumi, Kazuyuki Hayashi, Manabu Hishida, et al.. (2014). Two brothers with collagenofibrotic glomerulopathy. CEN Case Reports. 4(1). 85–89. 1 indexed citations

Aoki, Takafumi, et al.. (2014). Successful Treatment of Refractory Gout Using Combined Therapy Consisting of Febuxostat and Allopurinol in a Patient with Chronic Renal Failure. Internal Medicine. 53(6). 609–612. 11 indexed citations

Ito, Yasuhiko, Masashi Mizuno, Yasuhíro Suzuki, et al.. (2013). Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients. Journal of the American Society of Nephrology. 25(5). 1094–1102. 65 indexed citations

Okumura, Ataru, Kunïkazu Kondo, Hirofumi Tamai, et al.. (2002). Nephrogenic diabetes insipidus associated with hemochromatosis. American Journal of Kidney Diseases. 40(2). 403–406. 9 indexed citations

10.

Nokura, Kazuya, Hiroshi Koga, Hiroko Yamamoto, et al.. (2000). Dialysis-related spinal canal stenosis: a clinicopathological study on amyloid deposition and its AGE modification. Journal of the Neurological Sciences. 178(2). 114–123. 24 indexed citations

11.

Sasaki, Takaaki, et al.. (1998). Expression of tenascin in mesangial injury in experimental glomerulonephritis.. PubMed. 5(5). 423–8. 10 indexed citations

12.

Narabayashi, Isamu, Ryota Matsui, Hirofumi Tamai, et al.. (1998). Determination of normal values of Tmax and T1/2 of Tc-99m MAG3 renography in pediatric patients.. 39(5). 201–202. 1 indexed citations

13.

Tamai, Hirofumi, et al.. (1994). Tumor control dose for microscopic Lewis lung tumors and hypoxic radiosensitizer, RP-170. 6(4). 217–223. 2 indexed citations

14.

Fukatsu, A, Hirofumi Tamai, Kazuhiro Nishikawa, et al.. (1991). The kidney disease of Crow-Fukase (POEMS) syndrome: a clinico-pathological study of four cases.. PubMed. 36(2). 76–82. 25 indexed citations

15.

Suzuki, Takashi, Yasuhiko Ito, Hirofumi Tamai, et al.. (1991). A Case of Angiotropic Large Cell Lymphoma Manifesting Nephrotic Syndrome and Treated Successfully with Combination Chemotherapy. The Nephron journals/Nephron journals. 58(4). 479–482. 21 indexed citations

16.

Fukatsu, A, Sadao Matsuo, Hirofumi Tamai, et al.. (1991). Distribution of interleukin-6 in normal and diseased human kidney.. PubMed. 65(1). 61–6. 98 indexed citations

17.

Itoh, Ken, et al.. (1987). [Emphysematous pyelonephritis complicated by liver cirrhosis and diabetes mellitus: a case report and a review of the literature].. PubMed. 33(7). 1110–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact